GeoVax Labs, Inc. financial data

Symbol
GOVX, GOVXW on Nasdaq
Location
1900 Lake Park Drive, Suite 380, Smyrna, GA
State of incorporation
DE
Fiscal year end
December 31
Former names
DAUPHIN TECHNOLOGY INC (to 9/20/2006)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 145 % -76.3%
Debt-to-equity 23 % +66.9%
Return On Equity -853 % -986%
Return On Assets -327 % -402%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.26M shares -80.1%
Common Stock, Shares, Outstanding 4.18M shares -84.2%
Entity Public Float 14.4M USD +8.49%
Common Stock, Value, Issued 4.18K USD -84.2%
Weighted Average Number of Shares Outstanding, Basic 2.54M shares +62.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 21.9M USD +56%
General and Administrative Expense 5.66M USD -2.21%
Operating Income (Loss) -27.2M USD -37.5%
Nonoperating Income (Expense) -1.82K USD -101%
Net Income (Loss) Attributable to Parent -26.9M USD -39.3%
Earnings Per Share, Basic -12.7 USD/shares +29.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.56M USD -91.2%
Accounts Receivable, after Allowance for Credit Loss, Current 301K USD
Assets, Current 3.84M USD -80.6%
Property, Plant and Equipment, Net 171K USD -23.9%
Other Assets, Noncurrent 81K USD -93.2%
Assets 4.1M USD -80.7%
Accounts Payable, Current 3.98M USD +357%
Accrued Liabilities, Current 2.28M USD -29.1%
Liabilities, Current 6.4M USD +56.8%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 4.75M USD -36.1%
Retained Earnings (Accumulated Deficit) -115M USD -30.5%
Stockholders' Equity Attributable to Parent -2.31M USD -113%
Liabilities and Equity 4.1M USD -80.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.68M USD -51%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 150M shares -75%
Common Stock, Shares, Issued 4.18M shares -84.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.68M USD -51%
Deferred Tax Assets, Valuation Allowance 29.9M USD +30.7%
Deferred Tax Assets, Gross 30M USD +30.6%
Depreciation 12.3K USD +172%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Property, Plant and Equipment, Gross 890K USD +2.91%
Deferred Tax Assets, Operating Loss Carryforwards 25.5M USD +29.2%
Depreciation, Depletion and Amortization 19.6K USD +13%
Share-based Payment Arrangement, Expense 239K USD +178%
Interest Expense 0 USD -100%